CASI Annual ROE
-59.14%
-12.24%-26.10%
31 December 2023
Summary:
As of January 23, 2025, CASI annual return on equity is -59.14%, with the most recent change of -12.24% (-26.10%) on December 31, 2023. During the last 3 years, it has fallen by -10.18% (-20.79%). CASI annual ROE is now -149.96% below its all-time high of 118.38%, reached on December 31, 2015.CASI ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI Quarterly ROE
-137.00%
-48.13%-54.16%
01 September 2024
Summary:
As of January 23, 2025, CASI quarterly return on equity is -137.00%, with the most recent change of -48.13% (-54.16%) on September 1, 2024. Over the past year, it has dropped by -84.71% (-162.00%). CASI quarterly ROE is now -145.84% below its all-time high of 298.89%, reached on March 31, 2016.CASI Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CASI ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.1% | -162.0% |
| 3 y3 years | -20.8% | -162.0% |
| 5 y5 years | -59.3% | -162.0% |
CASI ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.6% | at low | -394.8% | at low |
| 5 y | 5-year | -70.6% | at low | -394.8% | at low |
| alltime | all time | -150.0% | +87.6% | -145.8% | +99.2% |
CASI Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -137.00%(+54.2%) |
| June 2024 | - | -88.87%(+20.3%) |
| Mar 2024 | - | -73.88%(+41.3%) |
| Dec 2023 | -59.14%(+26.1%) | -52.29%(-18.1%) |
| Sept 2023 | - | -63.83%(+10.8%) |
| June 2023 | - | -57.59%(+20.1%) |
| Mar 2023 | - | -47.95%(+4.4%) |
| Dec 2022 | -46.90%(+35.3%) | -45.94%(+65.9%) |
| Sept 2022 | - | -27.69%(-9.7%) |
| June 2022 | - | -30.67%(+8.7%) |
| Mar 2022 | - | -28.21%(-13.7%) |
| Dec 2021 | -34.66%(-29.2%) | -32.68%(-18.3%) |
| Sept 2021 | - | -40.01%(-16.8%) |
| June 2021 | - | -48.09%(-7.9%) |
| Mar 2021 | - | -52.24%(+5.1%) |
| Dec 2020 | -48.96%(+8.0%) | -49.71%(+3.1%) |
| Sept 2020 | - | -48.23%(+17.0%) |
| June 2020 | - | -41.22%(-7.5%) |
| Mar 2020 | - | -44.58%(+4.1%) |
| Dec 2019 | -45.32%(+22.1%) | -42.82%(+11.5%) |
| Sept 2019 | - | -38.42%(-0.5%) |
| June 2019 | - | -38.60%(+20.0%) |
| Mar 2019 | - | -32.18%(-3.4%) |
| Dec 2018 | -37.12%(+2.2%) | -33.30%(-8.8%) |
| Sept 2018 | - | -36.50%(+0.7%) |
| June 2018 | - | -36.24%(-9.6%) |
| Mar 2018 | - | -40.07%(-17.3%) |
| Dec 2017 | -36.31%(-71.8%) | -48.44%(+2.3%) |
| Sept 2017 | - | -47.36%(-7.1%) |
| June 2017 | - | -51.00%(-22.9%) |
| Mar 2017 | - | -66.18%(-36.5%) |
| Dec 2016 | -128.65%(-208.7%) | -104.16%(-51.2%) |
| Sept 2016 | - | -213.52%(-98.0%) |
| June 2016 | - | -10.71 K%(-3684.7%) |
| Mar 2016 | - | 298.89%(+66.9%) |
| Dec 2015 | 118.38%(-132.8%) | 179.10%(-34.2%) |
| Sept 2015 | - | 272.32%(-115.9%) |
| June 2015 | - | -1715.40%(+225.5%) |
| Mar 2015 | - | -527.03%(+68.8%) |
| Dec 2014 | -360.91%(+628.8%) | -312.22%(+40.1%) |
| Sept 2014 | - | -222.84%(+467.6%) |
| June 2014 | - | -39.26%(+2.5%) |
| Mar 2014 | - | -38.29%(-2.0%) |
| Dec 2013 | -49.52%(-81.7%) | -39.08%(+9.1%) |
| Sept 2013 | - | -35.83%(-4.6%) |
| June 2013 | - | -37.57%(-73.7%) |
| Mar 2013 | - | -142.90%(-39.4%) |
| Dec 2012 | -270.18%(+133.1%) | -235.82%(-13.8%) |
| Sept 2012 | - | -273.58%(-23.9%) |
| June 2012 | - | -359.31%(+101.5%) |
| Mar 2012 | - | -178.28%(+21.4%) |
| Dec 2011 | -115.92%(-75.6%) | -146.83%(+12.6%) |
| Sept 2011 | - | -130.36%(-14.2%) |
| June 2011 | - | -152.00%(-45.3%) |
| Mar 2011 | - | -277.97%(-30.7%) |
| Dec 2010 | -475.50% | -400.97%(-67.1%) |
| Sept 2010 | - | -1220.56%(-92.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2010 | - | -17.10 K%(+255.3%) |
| Mar 2010 | - | -4811.87%(+581.0%) |
| Dec 2009 | -411.21%(+182.8%) | -706.58%(+148.1%) |
| Sept 2009 | - | -284.75%(+25.5%) |
| June 2009 | - | -226.96%(+11.5%) |
| Mar 2009 | - | -203.62%(+21.3%) |
| Dec 2008 | -145.42%(+139.6%) | -167.82%(+26.8%) |
| Sept 2008 | - | -132.35%(+27.3%) |
| June 2008 | - | -103.95%(+32.5%) |
| Mar 2008 | - | -78.45%(+22.8%) |
| Dec 2007 | -60.69%(-53.6%) | -63.91%(-2.8%) |
| Sept 2007 | - | -65.74%(+3.2%) |
| June 2007 | - | -63.69%(+15.4%) |
| Mar 2007 | - | -55.19%(-56.5%) |
| Dec 2006 | -130.69%(+160.8%) | -126.75%(-0.9%) |
| Sept 2006 | - | -127.92%(-2.0%) |
| June 2006 | - | -130.49%(+4.3%) |
| Mar 2006 | - | -125.12%(+165.2%) |
| Dec 2005 | -50.11%(+40.1%) | -47.18%(+8.9%) |
| Sept 2005 | - | -43.31%(+5.5%) |
| June 2005 | - | -41.04%(-3.3%) |
| Mar 2005 | - | -42.46%(+0.3%) |
| Dec 2004 | -35.76%(-58.4%) | -42.35%(-38.3%) |
| Sept 2004 | - | -68.69%(-6.1%) |
| June 2004 | - | -73.13%(-14.2%) |
| Mar 2004 | - | -85.25%(-10.4%) |
| Dec 2003 | -85.90%(-62.9%) | -95.16%(-26.0%) |
| Sept 2003 | - | -128.64%(-52.2%) |
| June 2003 | - | -269.21%(-41.4%) |
| Mar 2003 | - | -459.12%(-2.7%) |
| Dec 2002 | -231.43%(+12.9%) | -471.67%(-12.9%) |
| Sept 2002 | - | -541.54%(+112.8%) |
| June 2002 | - | -254.44%(+26.8%) |
| Mar 2002 | - | -200.69%(+13.7%) |
| Dec 2001 | -204.92%(-13.8%) | -176.44%(+44.8%) |
| Sept 2001 | - | -121.82%(-24.3%) |
| June 2001 | - | -161.02%(+8.9%) |
| Mar 2001 | - | -147.90%(-7.8%) |
| Dec 2000 | -237.67%(+77.8%) | -160.37%(+11.5%) |
| Sept 2000 | - | -143.79%(-1.6%) |
| June 2000 | - | -146.07%(-2.4%) |
| Mar 2000 | - | -149.71%(+13.8%) |
| Dec 1999 | -133.69%(+272.8%) | -131.54%(+52.6%) |
| Sept 1999 | - | -86.21%(+11.7%) |
| June 1999 | - | -77.18%(+53.7%) |
| Mar 1999 | - | -50.20%(+41.8%) |
| Dec 1998 | -35.86%(+147.7%) | -35.40%(+29.8%) |
| Sept 1998 | - | -27.28%(+30.8%) |
| June 1998 | - | -20.86%(+10.8%) |
| Mar 1998 | - | -18.83%(+31.0%) |
| Dec 1997 | -14.48%(+43.9%) | -14.37%(+17.4%) |
| Sept 1997 | - | -12.24%(+10.4%) |
| June 1997 | - | -11.09%(-5.9%) |
| Mar 1997 | - | -11.78%(-10.6%) |
| Dec 1996 | -10.06% | -13.17%(+23.2%) |
| Sept 1996 | - | -10.69%(+27.1%) |
| June 1996 | - | -8.41%(-89.6%) |
| Mar 1996 | - | -80.95% |
FAQ
- What is CASI Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals annual ROE year-on-year change?
- What is CASI Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for CASI Pharmaceuticals?
- What is CASI Pharmaceuticals quarterly ROE year-on-year change?
What is CASI Pharmaceuticals annual return on equity?
The current annual ROE of CASI is -59.14%
What is the all time high annual ROE for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high annual return on equity is 118.38%
What is CASI Pharmaceuticals annual ROE year-on-year change?
Over the past year, CASI annual return on equity has changed by -12.24% (-26.10%)
What is CASI Pharmaceuticals quarterly return on equity?
The current quarterly ROE of CASI is -137.00%
What is the all time high quarterly ROE for CASI Pharmaceuticals?
CASI Pharmaceuticals all-time high quarterly return on equity is 298.89%
What is CASI Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, CASI quarterly return on equity has changed by -84.71% (-162.00%)